supported by the Na-tional Natural Science Foundation of China (Grant No. 30371317) to Kong Wei
The rapid growth of the global HIV/AIDS epidemic makes it a high priority to develop an effective vaccine.Since a live attenuated or inactivated HIV vaccine is not likely to be approved for clinical application due to...
the National Natural Science Foundation of China(No.30371317).
The virus-like particle(VLPs) vaccine is an ideal HIV-1 vaccine, which can simultaneously induce a neutralizing antibody reaction and cell-mediated immunity effectively. In this study, two kinds of plasmids have bee...
Supported by the National Natural Science Foundation of China(No30371317)
Highly attenuated modified vaccinia Ankara(MVA) is sensitive to repeat freeze-thaw cycle and easy to lose activity. In order to make the activity of MVA vaccine remain stable during its manufacturing, storage, and a...
Supported by the National Natural Science Foundation of China(No 30371317)
The induction of human immunodeficiency virus(HIV)-specific T-cell response is generally considered as critical to the development of effective immunity to HIV type 1 ( HIV-1 ). Recombinant Avipoxvirus vectors are...